This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA.
This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA.

This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA.

The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years.

Ashwin Urkude Article rating: 3.7

The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years.

Q1FY25 Results: NSE’s consolidated operating revenue up by 51 per cent YoY at Rs 4,510 crore!
Q1FY25 Results: NSE’s consolidated operating revenue up by 51 per cent YoY at Rs 4,510 crore!

Q1FY25 Results: NSE’s consolidated operating revenue up by 51 per cent YoY at Rs 4,510 crore!

NSE posted net profit of Rs 2,567 crore on a consolidated basis for Q1 FY25, up by 39 per cent on a year-on-year basis.

Vaishnavi Chauhan Article rating: 5.0

NSE posted net profit of Rs 2,567 crore on a consolidated basis for Q1 FY25, up by 39 per cent on a year-on-year basis.

Penny Stocks: Stocks likely to be in focus tomorrow!
Penny Stocks: Stocks likely to be in focus tomorrow!

Penny Stocks: Stocks likely to be in focus tomorrow!

The following penny stocks are likely to be in focus on Monday, August 05, 2024.

Vaishnavi Chauhan Article rating: 4.0

On Friday, the market witnessed muted sentiment, with the Sensex trading down by 1.08 per cent touching 80,981.96 mark, while Nifty decreased by 1.17 per cent breaking the level of 24,717.70 points.

Market wrap: The benchmark indices concluded the trading day on a positive note!
Market wrap: The benchmark indices concluded the trading day on a positive note!

Market wrap: The benchmark indices concluded the trading day on a positive note!

About 1,586 stocks were advancing as against to 2,375 that were declining, thus indicating a positive sentiment in the broader market.

Vaishnavi Chauhan Article rating: 5.0

About 1,586 stocks were advancing as against to 2,375 that were declining, thus indicating a positive sentiment in the broader market.

Penny Stocks: Stocks likely to be in focus tomorrow!
Penny Stocks: Stocks likely to be in focus tomorrow!

Penny Stocks: Stocks likely to be in focus tomorrow!

About 2,121 stocks were advancing as against to 1,833 that were declining, thus indicating a positive sentiment in the broader market.

Vaishnavi Chauhan Article rating: 4.1

About 2,121 stocks were advancing as against to 1,833 that were declining, thus indicating a positive sentiment in the broader market.

Market Update: The benchmark indices concluded the trading day on a positive note!
Market Update: The benchmark indices concluded the trading day on a positive note!

Market Update: The benchmark indices concluded the trading day on a positive note!

About 2,121 stocks were advancing as against to 1,833 that were declining, thus indicating a positive sentiment in the broader market.

Vaishnavi Chauhan Article rating: 5.0

About 2,121 stocks were advancing as against to 1,833 that were declining, thus indicating a positive sentiment in the broader market.

Market Update: The benchmark indices concluded the trading day on a negative note!
Market Update: The benchmark indices concluded the trading day on a negative note!

Market Update: The benchmark indices concluded the trading day on a negative note!

About 2,802 stocks were advancing as against to 1,094 that were declining, thus indicating a negative sentiment in the broader market.

Vaishnavi Chauhan Article rating: 2.5

About 2,802 stocks were advancing as against to 1,094 that were declining, thus indicating a negative sentiment in the broader market.

DSIJ MINDSHARE

Mkt Commentary18-Sep, 2024

Penny Stocks19-Sep, 2024

Multibaggers19-Sep, 2024

Penny Stocks19-Sep, 2024

Bonus and Spilt Shares19-Sep, 2024

Knowledge

Technical18-Sep, 2024

Personal Finance17-Sep, 2024

Personal Finance17-Sep, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR